BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our Industry eNewsletter FREE email:    
 Investor News
Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings
Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions 
Start-Ups
IPO News
IPO
 


Clinical - IND
Omeros Corporation (OMER) Release: Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 5/23/2013 9:49:59 AM    More...
Perosphere Inc. Receives FDA IND Clearance to Initiate Clinical Investigations of the Safety and Efficacy of PER977 to Reverse the Activity of Anticoagulation Therapies Including Factor Xa- and IIa-Inhibitors 5/22/2013 11:07:24 AM    More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 5/17/2013 9:36:51 AM    More...
Enanta Pharmaceuticals, Inc. Release: Breakthrough Therapy Designation From the FDA Granted to Investigational HCV Regimen Containing Protease Inhibitor ABT-450 5/6/2013 10:01:27 AM    More...
RNL Bio Files IND to Commence Phase II Clinical Trial of RNL-JointStem for Osteoarthritis in the United States 5/2/2013 11:09:42 AM    More...
R-Tech Ueno Receives FDA IND Approval for RU-101 (r-HSA) to Treat Severe Dry Eye 4/26/2013 10:10:16 AM    More...
SK Bio-Pharmaceuticals Announces FDA's Authorization of IND for SKL15508 4/17/2013 11:28:58 AM    More...
FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment 4/16/2013 10:56:42 AM    More...
Boston Therapeutics, Inc. Requests an IND Meeting With the FDA for PAZ320 to Reduce Postprandial Hyperglycemia in Type 2 Diabetes 4/11/2013 11:00:37 AM    More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Submits New IND Application for Oral Insulin Trial in the US 4/11/2013 9:42:51 AM    More...
Lipid Therapeutics Successfully Files a U.S. IND for LT-02, a Novel Barrier Function Therapy for Ulcerative Colitis 4/10/2013 9:45:46 AM    More...
ERYtech Pharma Receives FDA IND Clearance to Initiate a Clinical Study in Acute Lymphoblastic Leukemia in the U.S. 4/3/2013 10:57:29 AM    More...
Cleveland Biolabs Inc. (CBLI) and Incuron Announce Notice of Allowance From FDA to Commence Clinical Testing With CBL0137 4/2/2013 11:50:29 AM    More...
Soligenix (SNGX.OB) Receives IND Clearance From FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis 3/27/2013 10:16:51 AM    More...
Immunotech Laboratories in Discussions for Pre-"IND" Testing of Aids-HIV "IPF" Treatment in the USA 3/18/2013 9:29:40 AM    More...
1234567